Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use alfuzosin hydrochloride extended-release tablets safely and effectively. See full prescribing information for alfuzosin hydrochloride extended-release tablets. ALFUZOSIN hydrochloride extended-release tablets, USP for oral useInitial U.S. Approval: 2003
Medication labelWhy this: Advisory · dailymed-prescription
Alfuzosin hydrochloride extended-release tablets are indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. Alfuzosin hydrochloride extended-release tablets are not indicated for the treatment of hypertension. Alfuzosin hydrochloride extended-release tablets are not indicated for use in the pediatric population.
- generic_name
- alfuzosin
- product_names
- alfuzosin
- ndc
- 43353-746, 0378-5005, 43353-746-30, 43353-746-60
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en